Cartesian Therapeutics Inc (RNAC)
26.41
+0.07
(+0.27%)
USD |
NASDAQ |
May 17, 16:00
26.41
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Max Drawdown (5Y): 97.12% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 97.12% |
March 31, 2024 | 97.12% |
February 29, 2024 | 97.12% |
January 31, 2024 | 97.12% |
December 31, 2023 | 97.12% |
November 30, 2023 | 97.12% |
October 31, 2023 | 97.12% |
September 30, 2023 | 97.12% |
August 31, 2023 | 97.12% |
July 31, 2023 | 97.12% |
June 30, 2023 | 97.12% |
May 31, 2023 | 97.12% |
April 30, 2023 | 97.12% |
March 31, 2023 | 97.12% |
February 28, 2023 | 97.12% |
January 31, 2023 | 97.12% |
December 31, 2022 | 97.12% |
November 30, 2022 | 97.12% |
October 31, 2022 | 97.12% |
September 30, 2022 | 97.12% |
August 31, 2022 | 97.12% |
July 31, 2022 | 97.12% |
June 30, 2022 | 97.12% |
May 31, 2022 | 97.12% |
April 30, 2022 | 96.76% |
Date | Value |
---|---|
March 31, 2022 | 94.99% |
February 28, 2022 | 94.99% |
January 31, 2022 | 94.99% |
December 31, 2021 | 94.99% |
November 30, 2021 | 94.99% |
October 31, 2021 | 94.99% |
September 30, 2021 | 94.99% |
August 31, 2021 | 94.99% |
July 31, 2021 | 94.99% |
June 30, 2021 | 94.99% |
May 31, 2021 | 94.99% |
April 30, 2021 | 94.99% |
March 31, 2021 | 94.99% |
February 28, 2021 | 94.99% |
January 31, 2021 | 94.99% |
December 31, 2020 | 94.99% |
November 30, 2020 | 94.99% |
October 31, 2020 | 94.99% |
September 30, 2020 | 94.99% |
August 31, 2020 | 94.99% |
July 31, 2020 | 94.99% |
June 30, 2020 | 94.99% |
May 31, 2020 | 94.99% |
April 30, 2020 | 94.99% |
March 31, 2020 | 94.99% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
94.42%
Minimum
May 2019
97.12%
Maximum
May 2022
95.82%
Average
94.99%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
Marinus Pharmaceuticals Inc | 94.98% |
Adial Pharmaceuticals Inc | 99.30% |
Poseida Therapeutics Inc | -- |
Biomea Fusion Inc | -- |
NovaBay Pharmaceuticals Inc | 99.91% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -27.34 |
Beta (5Y) | 0.5376 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 95.09% |
Historical Sharpe Ratio (5Y) | -0.2246 |
Historical Sortino (5Y) | -0.5243 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 33.09% |